Envista Holdings
Open
$25.85
Prev. Close
$25.85
High
$25.85
Low
$25.85
Market Snapshot
$4.26B
90.6
-6.49
$2.51B
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,000 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Envista Holdings (NVST) saw a recent 2.2% decline, overshadowing its positive performance over the past month and year in the dental products industry.
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,000 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Recently from Cashu
Envista Holdings Reports Q4 2024 Growth Amid Strategic Transition and Operational Improvements
Envista Holdings Showcases Steady Progress Amid Strategic Transition Envista Holdings Corporation reveals its Q4 2024 results, emphasizing a notable recovery and operational improvements following a t…
Envista Holdings Announces Capital Markets Day for Strategic Insights on March 5, 2025
Envista Holdings Sets the Stage for Capital Markets Day in 2025 Envista Holdings Corporation, a prominent player in the global dental industry, announces its Capital Markets Day scheduled for March 5,…
Envista Holdings to Highlight Innovations at J.P. Morgan Healthcare Conference 2025
Envista Holdings to Showcase Innovations at J.P. Morgan Healthcare Conference Envista Holdings Corporation, a key player in the dental products industry, prepares to participate in the upcoming 43rd A…
Envista Holdings: QuidelOrtho Enhances Leadership with New Board Appointments for Strategic Growth
QuidelOrtho Strengthens Leadership with Strategic Board Appointments QuidelOrtho Corporation is set to enhance its governance and strategic direction with the appointments of John R. Chiminski and R.…